Drug recall · May 4, 2022
Losartan Potassium 50 mg Tablet recall
Why: CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Losartan Potassium 50 mg Tablet, a) 30-count blister card (NDC# 70518-3282-1), b) 60-count blister card (NDC: 70518-3282-0), Rx Only, MFG by: Lupin Pharma, Baltimore, MD 21202.
- Lots / codes
Lot # B1467803-120621, exp. date 06/30/2022 Lot # J0585793-121721, exp. date 12/31/2022
- Quantity
- 433/30 count blister cards, 33/60 count blister cards
- Company
- RemedyRepack Inc., Indiana, PA
- Distribution
- Product was distributed to customers in AK and PA.
- Initiated
- April 6, 2022 · Voluntary: Firm initiated
- Classified
- April 26, 2022
- Reported
- May 4, 2022
- Ended
- May 27, 2022
- How notified
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Losartan
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.